SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-003570
Filing Date
2023-03-13
Accepted
2023-03-13 16:03:09
Documents
8
Period of Report
2023-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230424xdef14a.htm DEF 14A 931302
2 GRAPHIC tmb-20230424xdef14a_a001.jpg GRAPHIC 6640
3 GRAPHIC tmb-20230424xdef14a_a002.jpg GRAPHIC 4232
4 GRAPHIC tmb-20230424xdef14a_a003.jpg GRAPHIC 8050
5 GRAPHIC tmb-20230424xdef14a_a008.jpg GRAPHIC 39269
6 GRAPHIC tmb-20230424xdef14a_a009.jpg GRAPHIC 36906
7 GRAPHIC tmb-20230424xdef14a_bg001.jpg GRAPHIC 131234
8 GRAPHIC tmb-20230424xdef14a_bg002.jpg GRAPHIC 132819
  Complete submission text file 0001558370-23-003570.txt   1428006
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38150 | Film No.: 23727279
SIC: 2834 Pharmaceutical Preparations